Search
Search Results
##search.searchResults.foundPlural##
-
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2554PDF: 805HTML: 288Figure 1: 164 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2110PDF: 1265Html: 276 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2387PDF: 934HTML: 378Supplementary table 1: 220Some of the mutation detection samples: 210 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
1983HTML: 536PDF: 1196 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1027PDF: 920Suppl. Files: 592HTML: 82 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3333PDF: 1025HTML: 1001Figure 1: 170 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1612PDF: 794HTML: 853jdoe, table 2 infections CML .doc: 193jdoe, table 1 infections CML .doc: 180 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1047PDF: 1039HTML: 93 -
Skin Involvement in Primary Systemic Amyloidosis
1610PDF: 884HTML: 4364Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 177Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 148Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 173 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1959PDF: 742HTML: 694 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1189PDF: 502HTML: 213 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1737PDF: 1280HTML: 11489Figure1: 170Figure 2: 171 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2244PDF: 830HTML: 2134New table Chinese children with APL: 160 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2129PDF: 1320HTML: 3499 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1704PDF: 831HTML: 142 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2392PDF: 1580HTML: 617 -
Simultaneous dual pathology in lymph node
1644PDF: 691HTML: 7688Simultaneous dual pathology in lymph node: 173Simultaneous dual pathology in lymph node: 171Simultaneous dual pathology in lymph node: 149Simultaneous dual pathology in lymph node: 188Simultaneous dual pathology in lymph node: 173 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2164PDF: 2000HTML: 169 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2131PDF: 827HTML: 924Patient’s family tree: 164 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2824PDF: 846HTML: 6518Untitled: 223Untitled: 185Untitled: 201Untitled: 207 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3865PDF: 751HTML: 1846 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2592PDF: 827HTML: 14945Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 301 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
2477PDF: 1154HTML: 11795 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1688PDF: 691HTML: 3795 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1180PDF: 1059HTML: 197 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2310PDF: 969HTML: 70 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2160PDF: 918HTML: 1633







